1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Persistant Allergic Rhinitis Global Clinical Trials Review, H2, 2014

Persistant Allergic Rhinitis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Persistant Allergic Rhinitis Global Clinical Trials Review, H2, 2014" provides data on the Persistant Allergic Rhinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Persistant Allergic Rhinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Persistant Allergic Rhinitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Persistant Allergic Rhinitis Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Persistant Allergic Rhinitis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Persistant Allergic Rhinitis 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Persistant Allergic Rhinitis Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Nuvo Research Inc. 30
Clinical Trial Overview of Nuvo Research Inc. 30
J Uriach Y Compania, S.A. 31
Clinical Trial Overview of J Uriach Y Compania, S.A. 31
Eurofarma Laboratorios S.A. 32
Clinical Trial Overview of Eurofarma Laboratorios S.A. 32
Theon Pharmaceuticals Ltd. 33
Clinical Trial Overview of Theon Pharmaceuticals Ltd. 33
Takeda Pharmaceutical Company Limited 34
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 34
Nuvo Research GmbH 35
Clinical Trial Overview of Nuvo Research GmbH 35
EMS S.A. 36
Clinical Trial Overview of EMS S.A. 36
Dong Wha Pharma Co., Ltd. 37
Clinical Trial Overview of Dong Wha Pharma Co., Ltd. 37
DCC Healthcare Limited 38
Clinical Trial Overview of DCC Healthcare Limited 38
Clinical Trial Overview of Top Institutes / Government 39
Department of Health, South Africa 39
Clinical Trial Overview of Department of Health, South Africa 39
National Research Council of Thailand 40
Clinical Trial Overview of National Research Council of Thailand 40
Istituto Giannina Gaslini 41
Clinical Trial Overview of Istituto Giannina Gaslini 41
The University of Sydney 42
Clinical Trial Overview of The University of Sydney 42
Five Key Clinical Profiles 43
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61

List of Tables
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Persistant Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Persistant Allergic Rhinitis Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Persistant Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nuvo Research Inc., 2014* 30
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by J Uriach Y Compania, S.A., 2014* 31
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eurofarma Laboratorios S.A., 2014* 32
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Theon Pharmaceuticals Ltd., 2014* 33
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 34
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nuvo Research GmbH, 2014* 35
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by EMS S.A., 2014* 36
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong Wha Pharma Co., Ltd., 2014* 37
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by DCC Healthcare Limited, 2014* 38
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014* 39
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Research Council of Thailand, 2014* 40
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Giannina Gaslini, 2014* 41
Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2014* 42

List of Figures
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Persistant Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Persistant Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 60

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.